← Back
$TNGX All transactions

Tango Therapeutics, Inc.

A

$ Value

$0

Shares

284,760

Price

$0

Filed

Feb 4

Insider

Name

Crystal Adam

Title

President, R&D

CIK

0001825445

Roles

Officer

Transaction Details

Transaction Date

2026-02-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

284,760

Footnotes

These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 1, 2027, 33% on February 14, 2028 and 34% on February 12, 2029, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. | The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. | Represents the weighted average sales price per share. The shares sold at prices ranging from $11.88 to $12.875 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. | Represents the weighted average sales price per share. The shares sold at prices ranging from $12.88 to $12.91 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. | This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2027 with the remaining option shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Filing Info

Accession No.

0001193125-26-038052

Form Type

4

Issuer CIK

0001819133

Crystal Adam's History

Date Ticker Type Value
2026-04-15 TNGX M $200K
2026-04-15 TNGX $962K
2026-04-15 TNGX M $0
2026-04-01 TNGX M $140K
2026-04-01 TNGX $572K
2026-04-01 TNGX M $0
2026-03-25 TNGX M $62K
2026-03-25 TNGX $241K
2026-03-25 TNGX M $0
2026-02-25 TNGX $694K

Other Insiders at TNGX (90d)

Insider Bought Sold Last
Beckman Daniella
Chief Financial Officer
$127K 2026-02-03
Weber Barbara
Director, Executive Chair
$374K 2026-02-03
Crystal Adam
President, R&D
$2.7M 2026-04-15